Currently used Food and Drug Administration-approved transplant drugs with the addition of an also already FDA-approved complement inhibitor are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark di
Currently used Food and Drug Administration-approved transplant drugs -; with the addition of an also already FDA-approved complement inhibitor -; are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators.
The regimen which relies solely on already FDA-approved medications showed remarkable success in Parsons model case series. Currently used Food and Drug Administration-approved transplant drugs with the addition of.
<p>UAB's latest peer-reviewed, published xenotransplant research establishes the optimal immunosuppression regimen for pig-to-human kidney transplants. The regimen consists of currently used Food and Drug Administration-approved transplant drugs with the addition of an also already FDA-approved complement inhibitor. It is a departure from what’s been tried before in most non-human primate experiments and living human heart transplants — but with a treatment regimen transplant doctors currently work with every day in human-to-human allotransplantation.</p>